Submit, track and review wealth intelligence cases.
Recurring market watches and one-time questions run asynchronously. Relationship managers can inspect agent work, review completed opportunities, and reopen historical cases from one queue.
NEW INTELLIGENCE CASE
Supporting documents
Entitlements, malware scan, document provenance and page-level citations remain attached throughout agent processing.
CASE MANAGEMENT
Statuses update asynchronously; inspect active agent work or open completed results.
| Case | Question / signal | Owner | Cadence | Status | Opportunity | Agent work | Action |
|---|
Eleanor Tan
UHNW household · Balanced Growth mandate · Relationship since 2014
Portfolio performance
Net return, SGD · September 2025 to August 2026
Strategic allocation
Current weight versus mandate target
Portfolio risk lens
Mandate-level controls after proposed trade
Exit hidden exposure and rotate into healthcare
Knowledge-enabled · RM judgement required
Top portfolio positions
Look-through exposure · market value in SGD
| Instrument | Asset class | Market value | Weight | YTD return | Contribution | Risk note |
|---|---|---|---|---|---|---|
| DBS Group HoldingsSGX · D05 | Equity | S$4.08M | 8.4% | +14.2% | +1.08% | Near concentration guide |
| Singapore Govt 3.0% 2034SGD sovereign | Fixed income | S$3.74M | 7.7% | +4.1% | +0.31% | Liquidity anchor |
| Global Healthcare FundInstitutional share class | Healthcare | S$3.16M | 6.5% | +9.8% | +0.62% | Sector overlap monitored |
| Asia Credit OpportunitiesPrivate debt vehicle | Alternatives | S$2.92M | 6.0% | +6.7% | +0.39% | Quarterly liquidity |
| US Treasury 4.125% 2031USD sovereign | Fixed income | S$2.58M | 5.3% | −1.2% | −0.07% | Partially FX hedged |
A 1.25% approved healthcare basket plus 0.75% MOD retains most thematic upside while reducing stressed single-name loss by S$146k.